StockData
CEL SCI Corp logo

CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.38−0.47 (-25.41%)

Close on Nov 18, 2026Market cap $24.27MP/E –Yield –

Cel Sci free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Cel Sci's free cash flow for the twelve months ending Jun 30, 2026 was -$16.75M. For fiscal 2025 it was -$17.16M. The highest annual figure on record is -$6.32M in fiscal 2009.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$17.16M–
FY2024Sep 30, 2024-$18.91M–
FY2023Sep 30, 2023-$23.21M–
FY2022Sep 30, 2022-$18.88M–
FY2021Sep 30, 2021-$27.80M–
FY2020Sep 30, 2020-$17.93M–
FY2019Sep 30, 2019-$16.14M–
FY2018Sep 30, 2018-$13.39M–
FY2017Sep 30, 2017-$13.80M–
FY2016Sep 30, 2016-$23.11M–
FY2015Sep 30, 2015-$23.91M–
FY2014Sep 30, 2014-$23.03M–
FY2013Sep 30, 2013-$13.65M–
FY2012Sep 30, 2012-$12.24M–
FY2011Sep 30, 2011-$22.77M–
FY2010Sep 30, 2010-$13.30M–
FY2009Sep 30, 2009-$6.32M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$4.03M–
Q2 FY2026CQ1 2026Mar 31, 2026-$4.02M–
Q1 FY2026CQ4 2025Dec 31, 2025-$4.02M–
Q4 FY2025CQ3 2025Sep 30, 2025-$4.68M–
Q3 FY2025CQ2 2025Jun 30, 2025-$3.94M–
Q2 FY2025CQ1 2025Mar 31, 2025-$4.37M–
Q1 FY2025CQ4 2024Dec 31, 2024-$4.17M–
Q4 FY2024CQ3 2024Sep 30, 2024-$4.84M–
Q3 FY2024CQ2 2024Jun 30, 2024-$4.60M–
Q2 FY2024CQ1 2024Mar 31, 2024-$4.53M–
Q1 FY2024CQ4 2023Dec 31, 2023-$4.94M–
Q4 FY2023CQ3 2023Sep 30, 2023-$5.04M–
Q3 FY2023CQ2 2023Jun 30, 2023-$5.86M–
Q2 FY2023CQ1 2023Mar 31, 2023-$7.58M–
Q1 FY2023CQ4 2022Dec 31, 2022-$4.72M–
Q4 FY2022CQ3 2022Sep 30, 2022-$4.93M–
Q3 FY2022CQ2 2022Jun 30, 2022-$5.86M–
Q2 FY2022CQ1 2022Mar 31, 2022-$3.27M–
Q1 FY2022CQ4 2021Dec 31, 2021-$4.82M–
Q4 FY2021CQ3 2021Sep 30, 2021-$5.19M–
Q3 FY2021CQ2 2021Jun 30, 2021-$7.20M–
Q2 FY2021CQ1 2021Mar 31, 2021-$8.44M–
Q1 FY2021CQ4 2020Dec 31, 2020-$6.98M–
Q4 FY2020CQ3 2020Sep 30, 2020-$4.71M–
Q3 FY2020CQ2 2020Jun 30, 2020-$4.48M–
Q2 FY2020CQ1 2020Mar 31, 2020-$4.54M–
Q1 FY2020CQ4 2019Dec 31, 2019-$4.20M–
Q4 FY2019CQ3 2019Sep 30, 2019-$3.88M–
Q3 FY2019CQ2 2019Jun 30, 2019-$4.31M–
Q2 FY2019CQ1 2019Mar 31, 2019-$3.79M–
Q1 FY2019CQ4 2018Dec 31, 2018-$4.16M–
Q4 FY2018CQ3 2018Sep 30, 2018-$4.24M–
Q3 FY2018CQ2 2018Jun 30, 2018-$2.78M–
Q2 FY2018CQ1 2018Mar 31, 2018-$3.75M–
Q1 FY2018CQ4 2017Dec 31, 2017-$2.61M–
Q4 FY2017CQ3 2017Sep 30, 2017-$3.44M–
Q3 FY2017CQ2 2017Jun 30, 2017-$3.13M–
Q2 FY2017CQ1 2017Mar 31, 2017-$3.00M–
Q1 FY2017CQ4 2016Dec 31, 2016-$4.24M–
Q4 FY2016CQ3 2016Sep 30, 2016-$6.86M–

More Cel Sci figures

See a number that looks wrong?